1. 74 Patient-oriented research priorities for pediatric hospital care in Canada: a James Lind Alliance Priority Setting Partnership. (21st October 2022) Authors: Gill, Peter; Bayliss, P; Breen-Reid, Karen; Buchanan, Francine; De Castris-Garcia, Kim; Green, Mairead; Frappier, Shelley; Quinlan, Michelle; Wong, Noel; Cowan, Katherine; Mahant, Sanjay Journal: Paediatrics & Child Health Issue: Volume 27: Supplement 3(2022) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2‐drug cocktail in patients with MET‐dysregulated advanced solid tumours: A phase I, multicentre, open‐label, single‐sequence drug–drug interaction study. Issue 7 (29th December 2020) Authors: Grande, Enrique; Giovannini, Monica; Marriere, Eddie; Pultar, Philippe; Quinlan, Michelle; Chen, Xinhui; Rahmanzadeh, Gholamreza; Curigliano, Giuseppe; Cui, Xiaoming Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 7(2021) Page Start: 2867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET‐dysregulated solid tumours. Issue 3 (17th October 2022) Authors: Chen, Xinhui; Isambert, Nicolas; López‐López, Rafael; Giovannini, Monica; Pognan, Nathalie; Kapoor, Shruti; Quinlan, Michelle; You, Benoit; Cui, Xiaoming; Rahmanzadeh, Gholamreza; Mau‐Sorensen, Morten Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 3(2023) Page Start: 1046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers. (13th July 2016) Authors: Zhou, Jocelyn; Quinlan, Michelle; Glenn, Kelli; Boss, Hildegard; Picard, Franck; Castro, Henry; Sellami, Dalila Journal: British journal of clinical pharmacology Issue: Volume 82:Number 4(2016:Oct.) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exposure‐Response Analysis of Sonidegib (LDE225), an Oral Inhibitor of the Hedgehog Signaling Pathway, for Effectiveness and Safety in Patients With Advanced Solid Tumors. (6th October 2016) Authors: Zhou, Jocelyn; Quinlan, Michelle; Hurh, Eunju; Sellami, Dalila Journal: Journal of clinical pharmacology Issue: Volume 56:Number 11(2016) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics of Asciminib in Individuals With Hepatic or Renal Impairment. (16th July 2021) Authors: Hoch, Matthias; Sato, Masahiko; Zack, Julia; Quinlan, Michelle; Sengupta, Tirtha; Allepuz, Alex; Aimone, Paola; Hourcade‐Potelleret, Florence Journal: Journal of clinical pharmacology Issue: Volume 61:Number 11(2021) Page Start: 1454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents. Issue 7 (26th May 2022) Authors: Hoch, Matthias; Huth, Felix; Sato, Masahiko; Sengupta, Tirtha; Quinlan, Michelle; Dodd, Stephanie; Kapoor, Shruti; Hourcade‐Potelleret, Florence Journal: Clinical and translational science Issue: Volume 15:Issue 7(2022) Page Start: 1698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics of Asciminib When Taken With Imatinib or With Food. Issue 2 (5th October 2021) Authors: Hoch, Matthias; Zack, Julia; Quinlan, Michelle; Huth, Felix; Forte, Sofia; Dodd, Stephanie; Aimone, Paola; Hourcade‐Potelleret, Florence Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 2(2022) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study. Issue 1 (18th June 2021) Authors: Chen, Xinhui; Cui, Xiaoming; Pognan, Nathalie; Quinlan, Michelle; Kapoor, Shruti; Rahmanzadeh, Gholamreza; Giovannini, Monica; Marbury, Thomas C. Other Names: Magavern Emma guestEditor.; Piasecki Jan guestEditor.; Cremers Serge guestEditor.; Cohen Adam guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 1(2022) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma. Issue 9 (12th July 2022) Authors: Forero‐Torres, Andres; Chandler, Jason Claud; Iyer, Swaminathan P.; Kanate, Abraham S.; Quinlan, Michelle; Hoever, Petra; Izquierdo, Miguel; Davis, Jaclyn; Madan, Sumit Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 9(2022) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗